Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
The specific 3H-spiperone binding to membrane homogenates of the striatum, mesolimbic area, and frontal cortex was examined in two groups of rats pretreated once daily with saline or 4 mg/kg of methamphetamine (MAP) for 14 days. At 7 days following cessation of chronic pretreatment, all rats received an injection of 4 mg/kg of MAP and were decapitated 1 hr after the injection. In the chronic saline-pretreatment group, the single administration of MAP induced significant changes in the number (Bmax) of specific 3H-spiperone binding sites (a decrease in the striatum and an increase in the mesolimbic area and frontal cortex), but no significant changes in the affinity (KD) in any brain area. The chronic MAP pretreatment markedly augmented the changes in Bmax in the striatum and mesolimbic area. The increase in specific 3H-spiperone binding sites in the mesolimbic area is discussed in relation to MAP-induced behavioral hypersensitivity.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002090:Butyrophenones / Q000378:metabolism*; D003342:Corpus Striatum / Q000032:analysis / Q000378:metabolism; D005625:Frontal Lobe / Q000032:analysis / Q000378:metabolism; D006801:Humans; D008032:Limbic System / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D011955:Receptors, Drug / Q000032:analysis / Q000187:drug effects / Q000378:metabolism; D013134:Spiperone / Q000032:analysis / Q000378:metabolism*; D013239:Stereotyped Behavior / Q000187:drug effects; D014316:Tritium
D002090:Butyrophenones; D011954:Receptors, Dopamine; D011955:Receptors, Drug; D014316:Tritium; D008694:Methamphetamine; D013134:Spiperone